Medicare Enrolled
Dr. Alan Carnes, M.D.
Urology Physician · Watkinsville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Carnes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Carnes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Carnes
Dr. Alan Carnes is an urology physician in Watkinsville, GA, with 12 years of NPI registration. Based on federal Medicare data, Dr. Carnes performed 3,047 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Carnes received a total of $5,813 from 49 pharmaceutical and/or device companies across 210 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Carnes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years of NPI registration
▲ Top 28% volume in GA
$5,813 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,047
Medicare services
Top 28% in GA for urology physician
Not available
Unique patients (not deduplicated)
$49
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
476 | $62 | $197 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
459 | $3 | $33 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
433 | $2 | $20 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
377 | $7 | $60 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
342 | $89 | $240 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
156 | $42 | $305 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
102 | $169 | $625 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
93 | $62 | $260 |
| Abdominal X-ray, 2 views An X-ray imaging test of the abdomen using two different angles to visualize internal structures. |
88 | $26 | $110 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
81 | $122 | $375 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 63 | $130 | $439 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
45 | $101 | $301 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
39 | $48 | $92 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
35 | $119 | $2,082 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
27 | $44 | $215 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
25 | $101 | $450 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
25 | $25 | $210 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
20 | $38 | $95 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
20 | $36 | $62 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
17 | $270 | $1,060 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
17 | $5 | $100 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
17 | $24 | $580 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
17 | $141 | $495 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
16 | $14 | $55 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $318 | $1,415 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
15 | $162 | $835 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $79 | $275 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
13 | $239 | $1,030 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
2.1% high complexity
19.6% medium
78.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,813
Total received (2018-2024)
Avg $830/year across 7 years
Top 38% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
49
Companies
210
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,231
2023
$787
2022
$644
2021
$776
2020
$254
2019
$1,616
2018
$506
Payments by company (2024)
Teleflex LLC
$172
PROCEPT BioRobotics Corporation
$163
Sumitomo Pharma America, Inc.
$149
Ferring Pharmaceuticals Inc.
$125
ABBVIE INC.
$112
Dendreon Pharmaceuticals LLC
$84
Myriad Genetic Laboratories, Inc.
$78
Janssen Biotech, Inc.
$75
Bayer Healthcare Pharmaceuticals Inc.
$51
UROGEN PHARMA, INC.
$46
Boston Scientific Corporation
$46
Endo USA, Inc.
$41
Astellas Pharma US Inc
$37
Agiliti Surgical, Inc.
$20
CIVCO Medical Instruments
$17
Calyxo, Inc.
$16
Top 3 companies account for 39.3% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$873
Boston Scientific Corporation
$597
Janssen Biotech, Inc.
$494
Astellas Pharma US Inc
$361
Bayer Healthcare Pharmaceuticals Inc.
$295
PROCEPT BioRobotics Corporation
$284
Bayer HealthCare Pharmaceuticals Inc.
$252
Endo Pharmaceuticals Inc.
$218
Myriad Genetic Laboratories, Inc.
$210
Teleflex LLC
$203
Sumitomo Pharma America, Inc.
$199
Dendreon Pharmaceuticals LLC
$171
Ferring Pharmaceuticals Inc.
$125
Progenics Pharmaceuticals, Inc.
$117
ABBVIE INC.
$112
PFIZER INC.
$110
Novartis Pharmaceuticals Corporation
$94
Olympus America Inc.
$81
Richard Wolf Medical Instruments Corp.
$80
C. R. Bard, Inc. & Subsidiaries
$80
Amgen Inc.
$69
AstraZeneca Pharmaceuticals LP
$67
AbbVie Inc.
$49
Myovant Sciences Inc.
$48
Rochester Medical Corporation
$47
UROGEN PHARMA, INC.
$46
ACCORD HEALTHCARE, INC.
$45
BOSTON SCIENTIFIC CORPORATION
$42
Endo USA, Inc.
$41
Intuitive Surgical, Inc.
$32
Coloplast Corp
$28
Ambu Inc.
$28
Blue Earth Diagnostics Limited
$26
UROVANT SCIENCES INC
$26
Metuchen Pharmaceuticals
$25
Axonics, Inc.
$24
Tolmar, Inc.
$21
Antares Pharma, Inc.
$21
Merck Sharp & Dohme LLC
$20
Agiliti Surgical, Inc.
$20
CIVCO Medical Instruments
$17
Acerus Pharmaceuticals Corporation
$17
Allergan Inc.
$16
Calyxo, Inc.
$16
Sun Pharmaceutical Industries Inc.
$15
Photocure Inc
$14
ROCHESTER MEDICAL CORPORATION
$13
Travere Therapeutics, Inc.
$13
Retrophin, Inc.
$12
Top 3 companies account for 33.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AFINITOR · AMS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Advantage System · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CVAC ASPIRATION SYSTEM · Cysview · Da Vinci Surgical System · ELIGARD · ENDOBEAM · ERLEADA · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL THERAPIES · GREENLIGHT · JELMYTO · KEYTRUDA · LYNPARZA · LithoVue · MYRBETRIQ · MYRISK · Myrbetriq · Natesto · Nubeqa · ORGOVYX · Olympus Cysto-Resection · Otrexup · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SPACEOAR · SPACEOAR VUE · ShockPulse - SE · Sonablate HIFU · SpaceOAR System · Stendra · Thiola · Titan · UROLIFT · VESICARE · XGEVA · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
13
County median income
$115,925
Nearest hospital to ZIP centroid (approximate)
ST MARY'S HOSPITAL
11.4 mi
11.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Carnes is a clinical cardiology specialist, with above-average Medicare volume (top 28% in GA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Carnes experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Carnes performed 476 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Carnes receive payments from pharmaceutical companies?
Yes. Dr. Carnes received a total of $5,813 from 49 companies across 210 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Carnes's costs compare to other urology physicians in Watkinsville?
Dr. Carnes's average Medicare payment per service is $49. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Carnes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Watkinsville
Browse urology physicians in Watkinsville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology